{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T16:31:30Z","timestamp":1777739490291,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T00:00:00Z","timestamp":1730332800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.clgc.2024.102257","type":"journal-article","created":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T19:30:38Z","timestamp":1730575838000},"page":"102257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Differential Analysis of Surgical Treatment Modalities in T2N0M0 Bladder Cancer Patients: A Novel Propensity Score-Based Cohort Study"],"prefix":"10.1016","volume":"23","author":[{"given":"Yu-Xuan","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gui-Chen","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Cheng","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuang-Di","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shao-Gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qi-Dong","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.clgc.2024.102257_bib0001","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clgc.2024.102257_bib0002","doi-asserted-by":"crossref","first-page":"329","DOI":"10.6004\/jnccn.2020.0011","article-title":"Bladder cancer, version 3.2020, NCCN clinical practice guidelines in oncology","volume":"18","author":"Flaig","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.clgc.2024.102257_bib0003","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.eururo.2020.03.055","article-title":"European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines","volume":"79","author":"Witjes","year":"2021","journal-title":"European Urology"},{"key":"10.1016\/j.clgc.2024.102257_bib0004","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.euo.2022.10.003","article-title":"Epidemiology, screening, and prevention of bladder cancer","volume":"5","author":"Lobo","year":"2022","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.clgc.2024.102257_bib0005","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nrurol.2017.82","article-title":"Landmarks in the treatment of muscle-invasive bladder cancer","volume":"14","author":"Lobo","year":"2017","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.clgc.2024.102257_bib0006","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/JU.0000000000002242","article-title":"Management trends and outcomes of patients undergoing radical cystectomy for urothelial carcinoma of the bladder: evolution of the university of southern california experience over 3,347 cases","volume":"207","author":"Mitra","year":"2022","journal-title":"J Urol"},{"key":"10.1016\/j.clgc.2024.102257_bib0007","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.eururo.2021.09.018","article-title":"Health-related quality of life for patients undergoing radical cystectomy: results of a large prospective cohort","volume":"81","author":"Clements","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2024.102257_bib0008","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.eururo.2008.07.031","article-title":"Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology","volume":"55","author":"Shabsigh","year":"2009","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2024.102257_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2023.104137","article-title":"Bladder-sparing treatment for muscle-invasive bladder carcinoma using immune checkpoint inhibitors","volume":"191","author":"Xu","year":"2023","journal-title":"Crit Rev Oncol\/Hematol."},{"key":"10.1016\/j.clgc.2024.102257_bib0010","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.eururo.2018.09.047","article-title":"Extended versus limited lymph node dissection in bladder cancer patients undergoing radical cystectomy: survival results from a prospective, randomized trial","volume":"75","author":"Gschwend","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2024.102257_bib0011","doi-asserted-by":"crossref","first-page":"960","DOI":"10.3390\/ijms25020960","article-title":"Photodynamic therapy: current trends and potential future role in the treatment of bladder cancer","volume":"25","author":"Kochergin","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.clgc.2024.102257_bib0012","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.eururo.2014.02.038","article-title":"Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review","volume":"66","author":"Ploussard","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2024.102257_bib0013","article-title":"Boosting photothermal theranostics via tict and molecular motions for photohyperthermia therapy of muscle-invasive bladder cancer","volume":"10","author":"Zeng","year":"2021","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.clgc.2024.102257_bib0014","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.cryobiol.2014.08.006","article-title":"Computed tomography imaging-guided percutaneous argon\u2013helium cryoablation of muscle-invasive bladder cancer: Initial experience in 32 patients","volume":"69","author":"Sun","year":"2014","journal-title":"Cryobiology"},{"key":"10.1016\/j.clgc.2024.102257_bib0015","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/php.13726","article-title":"Photodynamic therapy for bladder cancers, A Focused Review","volume":"99","author":"Rahman","year":"2023","journal-title":"Photochem Photobiol."},{"key":"10.1016\/j.clgc.2024.102257_bib0016","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.eururo.2023.08.016","article-title":"European association of urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2023 guidelines","volume":"85","author":"Alfred Witjes","year":"2024","journal-title":"Eur Urol"},{"key":"10.1016\/j.clgc.2024.102257_bib0017","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.euo.2023.02.008","article-title":"A systematic review of oncological outcomes associated with bladder-sparing strategies in patients achieving complete clinical response to initial systemic treatment for localized muscle-invasive bladder cancer","volume":"6","author":"Grobet-Jeandin","year":"2023","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.clgc.2024.102257_bib0018","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijsu.2021.106165","article-title":"STROCSS 2021: Strengthening the reporting of cohort, cross-sectional and case-control studies in surgery","volume":"96","author":"Mathew","year":"2021","journal-title":"Int J Surg"},{"key":"10.1016\/j.clgc.2024.102257_bib0019","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","article-title":"The central role of the propensity score in observational studies for causal effects","volume":"70","author":"Rosenbaum","year":"1983","journal-title":"Biometrika"},{"key":"10.1016\/j.clgc.2024.102257_bib0020","doi-asserted-by":"crossref","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","article-title":"X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization","volume":"10","author":"Camp","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clgc.2024.102257_bib0021","article-title":"Advances in diagnosis and treatment of bladder cancer","volume":"384","author":"Lopez-Beltran","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.clgc.2024.102257_bib0022","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1001\/jama.2020.17598","article-title":"Bladder cancer: a review","volume":"324","author":"Lenis","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.clgc.2024.102257_bib0023","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1016\/S0140-6736(22)01188-6","article-title":"Current best practice for bladder cancer: a narrative review of diagnostics and treatments","volume":"400","author":"Comp\u00e9rat","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.clgc.2024.102257_bib0024","first-page":"270","article-title":"Prognostic variations between \u2018primary\u2019 and \u2018progressive\u2019 muscle-invasive bladder cancer following radical cystectomy: a novel propensity score-based multicenter cohort study","volume":"110","author":"Lai","year":"2023","journal-title":"Int J Surg"},{"key":"10.1016\/j.clgc.2024.102257_bib0025","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.6004\/jnccn.2018.0072","article-title":"NCCN guidelines insights: bladder cancer, version 5.2018","volume":"16","author":"Flaig","year":"2018","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.clgc.2024.102257_bib0026","first-page":"404","article-title":"Treatment of muscle-invasive and advanced bladder cancer in 2020","volume":"70","author":"Patel","year":"2020","journal-title":"CA A Cancer J Clinicians"},{"key":"10.1016\/j.clgc.2024.102257_bib0027","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.juro.2006.06.015","article-title":"The effects of adjusting for case mix on mortality and length of stay following radical cystectomy","volume":"176","author":"Hollenbeck","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.clgc.2024.102257_bib0028","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.euf.2023.05.002","article-title":"Complications after radical cystectomy: a systematic review and meta-analysis of randomized controlled trials with a meta-regression analysis","volume":"9","author":"Katsimperis","year":"2023","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.clgc.2024.102257_bib0029","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.urology.2017.01.036","article-title":"An evaluation of the timing of surgical complications following radical cystectomy: data from the American college of surgeons national surgical quality improvement program","volume":"103","author":"Sood","year":"2017","journal-title":"Urology"},{"key":"10.1016\/j.clgc.2024.102257_bib0030","doi-asserted-by":"crossref","first-page":"9365","DOI":"10.1002\/cam4.3552","article-title":"Alterations of DNA damage response genes correlate with response and overall survival in anti-PD-1\/PD-L1-treated advanced urothelial cancer","volume":"9","author":"Joshi","year":"2020","journal-title":"Cancer Med"},{"key":"10.1016\/j.clgc.2024.102257_bib0031","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1056\/NEJMoa022148","article-title":"Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer","volume":"349","author":"Grossman","year":"2003","journal-title":"N Engl J Med"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767324002271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767324002271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T15:19:10Z","timestamp":1753111150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767324002271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S1558767324002271"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2024.102257","relation":{},"ISSN":["1558-7673"],"issn-type":[{"value":"1558-7673","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differential Analysis of Surgical Treatment Modalities in T2N0M0 Bladder Cancer Patients: A Novel Propensity Score-Based Cohort Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2024.102257","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102257"}}